Internal Medicine · Syracuse, NY
NPI
1174501498
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4900 Broad Rd, Pob Ste 4k
Syracuse, NY, 13215
Phone (315) 492-5784
Groups this clinician bills Medicare through
Medicare paid, 2024
$147K
3,723 services
Medicare patients, 2024
439
Average age 74
Drug cost, 2024
$2.6M
8,074 prescriptions
Company payments, 2025
$2,220
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell V Brodey was code 99214 (office e&m - established), 350 times for 187 patients. In total Mitchell V Brodey billed 3,723 services in 99 codes, and Medicare paid $147K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 350 | 187 | $84.91 | $30K |
| 36415 Venipuncture Blood Collection | Office | 319 | 178 | $8.57 | $2,733 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 260 | 158 | $11.55 | $3,003 |
| 80053 Clinical Chemistry | Office | 260 | 158 | $10.23 | $2,660 |
| 80061 Clinical Chemistry | Office | 233 | 137 | $13.06 | $3,044 |
| 85025 Blood Count | Office | 225 | 147 | $7.51 | $1,689 |
| 99231 Hospital E&M - Subsequent | Facility | 200 | 114 | $35.71 | $7,141 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 179 | 34 | $42.81 | $7,663 |
| 99232 Hospital E&M - Subsequent | Facility | 168 | 95 | $58.13 | $9,767 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 162 | 30 | $30.87 | $5,001 |
| 99222 Hospital E&M - Initial | Facility | 160 | 127 | $91.78 | $15K |
| 83036 Blood Count | Office | 98 | 48 | $9.52 | $933 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 98 | 98 | $122.97 | $12K |
| 99213 Office E&M - Established | Office | 84 | 61 | $60.84 | $5,111 |
| 99223 Hospital E&M - Initial | Facility | 80 | 76 | $121.32 | $9,706 |
By year: 2022 $144K for 3,478 services; 2023 $148K for 3,789 services; 2024 $147K for 3,723 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 319 | 178 | $8.57 | $2,733 |
| 80053 Clinical Chemistry | 260 | 158 | $10.23 | $2,660 |
| 80061 Clinical Chemistry | 233 | 137 | $13.06 | $3,044 |
| 85025 Blood Count | 225 | 147 | $7.51 | $1,689 |
| 83036 Blood Count | 98 | 48 | $9.52 | $933 |
| 84443 Clinical Chemistry | 52 | 34 | $16.46 | $856 |
| 84439 Clinical Chemistry | 47 | 30 | $8.84 | $415 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 33 | 33 | $18.92 | $624 |
| 82043 Clinical Chemistry | 33 | 26 | $5.66 | $187 |
| 82570 Clinical Chemistry | 30 | 25 | $4.96 | $149 |
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell V Brodey prescribed most often to Medicare patients was Atorvastatin Calcium, with 418 prescriptions and refills. In total Mitchell V Brodey wrote 8,074 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 418 | 1,218 | 126 | $4,367 |
| Rosuvastatin Calcium Generic | 417 | 1,141 | 123 | $3,746 |
| Amlodipine Besylate Generic | 322 | 905 | 91 | $1,421 |
| Losartan Potassium Generic | 231 | 647 | 67 | $1,671 |
| Levothyroxine Sodium Generic | 171 | 485 | 46 | $2,848 |
| Irbesartan Generic | 161 | 434 | 41 | $2,459 |
| Gabapentin Generic | 142 | 226 | 32 | $1,542 |
| Metformin Hcl Er Metformin Hcl | 138 | 391 | 39 | $989 |
| Montelukast Sodium Generic | 126 | 310 | 28 | $1,066 |
| Omeprazole Generic | 126 | 373 | 36 | $1,270 |
| Methenamine Hippurate Generic | 118 | 128 | 20 | $5,698 |
| Pantoprazole Sodium Generic | 116 | 267 | 31 | $956 |
| Trazodone Hcl Generic | 98 | 197 | 23 | $559 |
| Meloxicam Generic | 94 | 143 | 34 | $301 |
| Amoxicillin Generic | 91 | 139 | 29 | $1,064 |
Brand drugs: 1,340 claims; generic drugs: 6,689 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitchell V Brodey $2,220 ($2,220 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novo Nordisk Inc with $356.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $356 |
| ViiV Healthcare Company GSK | 5 | $215 |
| Gilead Sciences, Inc. GILD | 15 | $212 |
| Madrigal Pharmaceuticals MDGL | 8 | $210 |
| Abbvie Inc. ABBV | 15 | $206 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $94.98 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $80.37 |
| Merck Sharp & Dohme LLC MRK | 4 | $78.38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.